Preeclampsia is associated with oxidative stress in maternal circulation. The purpose of this study was to explore oxidative stress and antioxidants in the fetal circulation in preeclampsia. Women with preeclampsia (n ϭ 19) or uncomplicated pregnancies (n ϭ 33) delivered by cesarean section were included. Blood was sampled separately from the umbilical vein and artery. 8-Isoprostaglandin F 2␣ (8-isoprostane), a stable product of lipid peroxidation, is a reliable marker of oxidative stress. Concentration of total 8-isoprostane in cord plasma was analyzed by gas chromatographymass spectrometry. Antioxidant status was evaluated measuring ferric reducing ability of plasma and vitamin E. There was no difference between preeclampsia and control groups regarding median plasma concentration of 8-isoprostane in umbilical vein (955 versus 780 pg/mL, p ϭ 0.41) or in umbilical artery (233 versus 276 pg/mL, p ϭ 0.65). Concentration of 8-isoprostane was much higher in plasma from the umbilical vein than artery, suggesting placenta as the source of 8-isoprostane. Median ferric reducing ability of plasma concentration was higher in preeclampsia than in controls, both in the umbilical vein and artery. Median vitamin E concentration in the umbilical vein was higher in preeclampsia, but no difference was found in the umbilical artery. In conclusion, no evidence of increased oxidative stress, evaluated by 8-isoprostane concentration, was found in fetal circulation in preeclampsia. (Pediatr Res 60: 560-564, 2006) P reeclampsia is a pregnancy specific disorder, characterized by hypertension and proteinuria developing in the second half of the pregnancy. For the fetus, the preeclampsia syndrome could have serious consequences, including increased risk of fetal growth restriction and induced premature delivery due to disease progression on the maternal or fetal side. Maternal endothelial dysfunction is believed to be the common final pathway leading to the syndrome of preeclampsia. A dominating hypothesis is that agents produced by the relatively hypoxic placenta is transferred to the maternal circulation, causing endothelial dysfunction (1). Several candidates have been proposed as possible agents that directly or indirectly could mediate the endothelial dysfunction, including lipid peroxidation products (2,3), activated leukocytes (4), placental debris (5), or sFlt1, a vascular endothelial growth factor (VEGF) antagonist (6). To what extent such placental agents affect the fetus, or are present in the fetal circulation at increased concentrations in preeclampsia, has not been fully explored. Few studies have addressed this issue, with conflicting results (7-10). If endothelial activating agents are present in the fetal circulation, they could cause immediate effects, such as endothelial activation, or even long-term consequences, such as the programming of adult diseases. The concept of intrauterine fetal programming, that an individual's adult health could be influenced by conditions and growth in utero, is convincingly do...